Using Ultrasensitive PSA Assays in Routine Practice

EP: 1.An Overview of the ARANOTE Trial

EP: 2.Comparing Trials Studying Treatment Intensification In mHSPC

EP: 3.Post Hoc Analysis of ARANOTE; Ultra-Low PSA Responses

EP: 4.Clinical Outcomes of Ultra-Low PSA Responses in Patients With mHSPC Receiving Darolutamide Plus ADT

EP: 5.Ultra-Low PSA Threshold vs Traditional Thresholds In Clinical Practice

EP: 6.Interpreting PSA Trends in Patients Receiving Darolutamide Plus ADT With mHSPC

EP: 7.Ultra-Low PSA Response as a Trial End Point or Clinical Decision Point

Now Viewing

EP: 8.Using Ultrasensitive PSA Assays in Routine Practice

EP: 9.The Use of Ultra-Low PSA in Specific Patient Profiles

EP: 10.Selecting Between Receptor Pathway Inhibitors for mHSPC

Practical Considerations for Ultrasensitive PSA Testing

Key Themes:

• Feasibility of implementing ultrasensitive PSA assays in community practice
• Logistical challenges including cost and standardization
• Clinical interpretation considerations

Expert Insights:

• Dr Shore addressed the practicality of using ultrasensitive PSA assays in routine clinical practice.

The discussion covered pros and cons, cost implications, assay standardization challenges, and the nuances of clinical interpretation.